Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Daniel Ahn's Talks
Daniel Ahn
Mayo Clinic Arizona
zanidatamab and 2nd interim OS analysis
September 1, 2026
Daniel Ahn
Mayo Clinic Arizona
00:00
--:--
zanidatamab approved in GEA cancers
August 31, 2026
Share
zanidatamab approved in GEA cancers
https://www.medspoke.co/channel_playlist?object_id=796&tap_id=13617
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Daniel Ahn
Mayo Clinic Arizona
FDA approval of daraxonrasib in PDAC
August 31, 2026
Why are you reporting this TALK?
